Skip to content

Chronic renal failure hemodialysis vascular access set up and combine traditional Chinese and western medicine to prevention and treatment of complications and continuous quality improvement

Chronic renal failure hemodialysis vascular access set up and combine traditional Chinese and western medicine to prevention and treatment of complications and continuous quality improvement

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015234
Enrollment
Unknown
Registered
2018-03-16
Start date
2018-03-23
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

Tanshinone group:After completion of arteriovenous anastomosis, basic treatment was given. A week later, 5% Glucose Injection 100ml+ tanshinone injection (tanshinone A sulfonate sodium injection) was
Basic treatment group :After arteriovenous anastomosis, infrared radiation was used for anastomosis, once a day, 30 minutes each time, and one week for a month.

Sponsors

Shuguang Hospital, affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) predialysis of chronic renal failure and consent to action venous anastomosis; (2) Aged 18-80 years; (3) the signing of the informed consent.

Exclusion criteria

Exclusion criteria: (1) patients who did not conform to chronic renal failure; (2) the refusal of arteriovenous anastomosis; (3) people with serious primary diseases such as heart, brain, liver and hematopoiesis; (4) after kidney transplantation, patients with psychosis; (5) patients with acute renal failure; (6) pregnant or lactating women; (7) patients who are known to be allergic to the drugs used; (8) people who are participating in other drug clinical trials or in other clinical trials within 3 months or other drugs that have been used to control thrombus.

Design outcomes

Primary

MeasureTime frame
Blood flow;Vascular diameter;Diameter of arteriovenous anastomotic stoma;Blood rheology;

Secondary

MeasureTime frame
Serum endothelin;Serum nitric oxide;

Countries

China

Contacts

Public ContactYe Chaoyang

Shuguang Hospital, affiliated to Shanghai University of Traditional Chinese Medicine

yechaoyang63@126.com+86 021-20256182

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026